| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |